92 related articles for article (PubMed ID: 7712517)
1. [Local production of eicosanoids in patients with ulcerative colitis].
Lukás K; Lukás M; Jáchymová M
Cas Lek Cesk; 1995 Jan; 134(1):13-7. PubMed ID: 7712517
[TBL] [Abstract][Full Text] [Related]
2. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
[TBL] [Abstract][Full Text] [Related]
3. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
Hillingsø J; Kjeldsen J; Laursen LS; Lauritsen K; von Spreckelsen S; Depré M; Friedman BS; Malmström K; Shingo S; Bukhave K
Clin Pharmacol Ther; 1995 Mar; 57(3):335-41. PubMed ID: 7697951
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of rectal dialysis to determine intrarectal eicosanoids release in ulcerative colitis.
Casellas F; Borruel N; Papo M; Antolín M; Armengol JR; Malagelada JR
Rev Esp Enferm Dig; 1997 Apr; 89(4):280-8. PubMed ID: 9168661
[TBL] [Abstract][Full Text] [Related]
5. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026
[TBL] [Abstract][Full Text] [Related]
6. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
[TBL] [Abstract][Full Text] [Related]
7. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
8. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
Sharon P; Ligumsky M; Rachmilewitz D; Zor U
Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669
[TBL] [Abstract][Full Text] [Related]
9. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
10. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
[TBL] [Abstract][Full Text] [Related]
11. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study.
Aslan A; Triadafilopoulos G
Am J Gastroenterol; 1992 Apr; 87(4):432-7. PubMed ID: 1553930
[TBL] [Abstract][Full Text] [Related]
12. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
[TBL] [Abstract][Full Text] [Related]
13. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.
Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
Gastroenterology; 1988 Jul; 95(1):11-7. PubMed ID: 2836256
[TBL] [Abstract][Full Text] [Related]
14. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis of eicosanoids in the colonic mucosa in patients with ulcerative colitis].
Pavlenko VV; Iagoda AV
Klin Med (Mosk); 2003; 81(10):39-43. PubMed ID: 14664173
[TBL] [Abstract][Full Text] [Related]
16. Rectal blood flow in ulcerative colitis.
Guslandi M; Polli D; Sorghi M; Tittobello A
Am J Gastroenterol; 1995 Apr; 90(4):579-80. PubMed ID: 7717314
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
18. Ileo-rectal anastomosis in ulcerative colitis: results of a long-term follow-up study.
Paoluzi OA; Di Paolo MC; Ricci F; Pasquali C; Iacucci M; Paoluzi P
Ital J Gastroenterol; 1994; 26(8):392-7. PubMed ID: 7703514
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.
Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
Gut; 1987 Sep; 28(9):1095-9. PubMed ID: 2824300
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
